Vaccines

A study that put both COVID-19 shots to the test to see which was better for older adults found that the Moderna vaccine was superior.

At last. I haven’t worn a mask in public in months, I’m starting to see friends again, I’m eating in restaurants again, and my new normal is the old normal. Life is good.  There’s some hesitation...

It’s going to be a pretty busy cold, flu and respiratory syncytial virus season, according to the US Centers for Disease Control and Prevention. COVID-19 is on the rise now, a year after the country...

Earlier this year, the US Centers for Disease Control and Prevention endorsed two new vaccines for respiratory syncytial virus in older adults. Now the agency has added some new guidance on using the RSV...

CDC director Rochelle Walensky has greenlit the use of two new respiratory syncytial virus (RSV) vaccines for preventing severe disease in older adults, emphasizing their use in vulnerable groups such...

The Centers for Medicare & Medicaid Services has released more information on mandatory state Medicaid and CHIP program coverage of vaccines recommended for adults.

COVID-19 mRNA vaccination was 31% effective against infection for nursing home residents who were up to date on their shots between November 2022 and January 2023, according to the CDC’s latest data...

A panel of experts decided that people aged 60 years and older may receive either of two recently approved vaccines for preventing respiratory syncytial virus infections. But the recommendation is not...

Pfizer’s Abrysvo was found to be 67% effective in preventing confirmed RSV in cases with two symptoms, and even more effective in preventing disease with three or more symptoms, clinical trial data...

The Food and Drug Administration reportedly is considering a new round of COVID-19 booster shots for individuals who are at high risk of severe disease, including those aged 65 or more years or those who...